Investigating how to enhance lung defenses against pneumonia complications
Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia
This study is looking at a new inhaled treatment that helps strengthen your lungs' natural defenses against pneumonia, and it's designed to find out who might benefit the most from it to help improve care for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11038043 on NIH RePORTER |
What this research studies
This research focuses on understanding how the lungs can be better protected from pneumonia and its complications. It explores a novel inhaled therapy that stimulates the lungs' natural defenses using a combination of synthetic agents. By studying the mechanisms behind this inducible resistance, the research aims to identify which patients may benefit most and develop more effective treatments for pneumonia. The approach involves testing hypotheses and building on findings to improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for pneumonia, such as those with chronic lung diseases or weakened immune systems.
Not a fit: Patients who do not have respiratory issues or are not at risk for pneumonia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly reduce the incidence and severity of pneumonia and its long-term complications.
How similar studies have performed: Previous research has shown promise in enhancing lung defenses through similar therapeutic approaches, indicating potential for success in this area.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Evans, Scott E. — University of Tx Md Anderson Can Ctr
- Study coordinator: Evans, Scott E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.